Search Within

Roisin Eilish O'Cearbhaill

Formats
  1. Meeting Abstract (128)
  2. Journal Article (125)
  3. Review (9)
  4. Editorial (6)
  5. Book Section (3)
  6. Guidelines (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (274)
  2. GDMT, Medicine (274)
  3. Gynecologic Medicine Service (274)
  4. Gynecology Disease Management Team (274)
  5. Hematologic Malignancies, Division of (274)
  6. Solid Tumor Oncology Division (274)

More Groups

People
  1. Carol Aghajanian (99)
  2. Alexia Iasonos (75)
  3. Qin Zhou (68)
  4. Rachel Grisham (68)
  5. Dennis Chi (67)
  6. William Tew (66)

More People

Years
  1. 2025 (16)
  2. 2024 (30)
  3. 2023 (43)
  4. 2022 (31)
  5. 2021 (25)
  6. 2020 (41)

More Years

Publications
  1. Gynecologic Oncology (91)
  2. Journal of Clinical Oncology (46)
  3. International Journal of Gynecological Cancer (39)
  4. Annals of Oncology (13)
  5. Gynecologic Oncology Reports (11)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier B.V. (102)
  2. American Society of Clinical Oncology (49)
  3. Lippincott Williams & Wilkins (40)
  4. Oxford University Press (14)
  5. American Association for Cancer Research (13)
  6. Nature Publishing Group (10)

More Publishers

Results (274)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center
    Journal Article

    Filippova, O. T.; Chi, D. S.; Long Roche, K.; Sonoda, Y.; Zivanovic, O.; Gardner, G. J.; Tew, W. P.; O'Cearbhaill, R.; Sarraf, S.; Sun, S. W.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: A dose-escalation and dose-expansion phase 1b trial
    Journal Article

    Konstantinopoulos, P. A.; Barry, W. T.; Birrer, M.; Westin, S. N.; Cadoo, K. A.; Shapiro, G. I.; Mayer, E. L.; O'Cearbhaill, R. E.; Coleman, R. L.; Kochupurakkal, B.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • The experience of being aware of disease status in women with recurrent ovarian cancer: A phenomenological study
    Journal Article

    Finlayson, C. S.; Fu, M. R.; Squires, A.; Applebaum, A.; Van Cleave, J.; O'Cearbhaill, R.; DeRosa, A. P.
    Journal of Palliative Medicine (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A phase II evaluation of nivolumab, a fully human antibody against PD-1, in the treatment of persistent or recurrent cervical cancer
    Meeting Abstract

    Santin, A.; Deng, W.; Frumovitz, M. M.; Huh, W. K.; Khleif, S.; Lankes, H. A.; Ratner, E.; O'Cearbhaill, R.; Jazaeri, A. A.; Birrer, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy regimen selection in high-grade ovarian carcinoma: Comparing dose-dense chemotherapy with an every-three-week regimen
    Meeting Abstract

    Mueller, J.; Byrne, M.; Zhou, Q.; Iasonos, A.; Zivanovic, O.; Long Roche, K.; Tew, W.; Chi, D.; Gardner, G.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • A phase Ib study of miransertib (ARQ 092) in combination with anastrozole in patients with PIK3CA or AKT1-mutant ER+ endometrial or ovarian cancer
    Meeting Abstract

    Hyman, D.; Bonafede, M.; O'Cearbhaill, R.; Grisham, R.; Zamarin, D.; Tew, W.; Aghajanian, C.; Cadoo, K.; Friedman, C.; Savage, R. E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Wolfer, A.; Disilvestro, P.; O'Malley, D. M.; Sabbatini, P.; Shohara, L.; Schwarzenberger, P. O.; Ricciardi, T.; Macri, M.; Ryan, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save